Berkeley Lights, Inc.

27 articles with Berkeley Lights, Inc.

• Ginkgo Bioworks and Berkeley Lights Bring Unprecedented Speed and Scale to Synthetic Biology with $150MM Collaboration

  10/1/2019

  Collaboration brings best-in-class technology to Ginkgo foundries, with a commitment to ongoing joint technology development

• Berkeley Lights Opens Shanghai Location

  9/5/2019

  Berkeley Lights, Inc. announced the opening of a representative office in Pudong, Shanghai.

• 

  BioSpace Movers and Shakers, Aug. 9

  8/9/2019

  Biopharma companies strengthen their senior leadership teams and boards of directors.

• Berkeley Lights to Launch New T Cell Functional Analytics Platform at the 34ᵗʰ Congress of the International Society for Advancement of Cytometry (CYTO)

  6/18/2019

  Berkeley Lights, Inc. announced the launch of the LightningTM optofluidic platform, which directly visualizes phenotype and function of 1000s of T cells in days to help scientists address challenges in developing cancer immunotherapies.

• Abveris Deploys the Berkeley Lights Beacon® Platform for Antibody Discovery

  6/17/2019

  Abveris will be launching a sister company, AbX Biologics, with an exclusive focus on therapeutic antibody discovery services.

• Berkeley Lights Selected as One of the World's Most Innovative Companies of 2019 by Fast Company

  2/20/2019

  Berkeley Lights, Inc., a leader in digital cell biology, announced that it has been named one of Fast Company's 2019 Most Innovative Companies in Biotech.

• 

  Up-and-Coming Automation Company Berkeley Lights Raises $95 Million

  10/15/2018

  Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
• 

  Movers and Shakers for Sept. 4

  9/4/2018

  Biopharm companies closed out August with a plethora of changes to executive and senior leadership positions. Let's take a look.

• Shire Adopts Berkeley Lights' Beacon OptoFluidic Platform to Speed Cell Line Development

  1/30/2018

  Shire's decision was based on a study that compared their existing CLD workflow to a workflow using the Beacon.

• Another Large Pharma Implements Berkeley Lights' Beacon OptoFluidic Platform for Accelerating Antibody Discovery

  1/16/2018

  Berkeley Lights announced today that Novartis is implementing BLI's Beacon platform to help accelerate their antibody discovery workflow.

• Berkeley Lights Announces Research Collaboration and License Agreement With Pfizer

  1/4/2018

  Through the collaboration, the companies will combine BLI's platform - which utilizes a light-based, nano-fluidic method to select, characterize, culture and export single cells - with Pfizer's expertise in gene editing, sequencing, and molecular biology, as well as B-cell screening, to help advance the research aims and influence the development of the Beacon platform.

• Daiichi Sankyo Working with Berkeley Lights' Beacon OptoFluidic Platform for Cell Line Development

  10/30/2017

  Berkeley Lights announced today a program with Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.

• Berkeley Lights Selects Tekon As Partner To Expand Into Chinese Market

  10/3/2017

• Berkeley Lights Automates Biological Processing To Reduce Drug Development Timelines And Bring Therapies To Market Faster

  9/12/2017

• Berkeley Lights Announces Strategic Project With Bayer Focused On Cell Line Development And Antibody Discovery

  9/12/2017

• Berkeley Lights Announces Cell Line Development Program

  6/27/2017

• Berkeley Lights Announces GlaxoSmithKline Adoption Of The Beacon OptoFluidic Platform

  6/13/2017

• Berkeley Lights Announces Expanded Adoption Of The Beacon Opto-Fluidic Platform

  5/15/2017

• Berkeley Lights Announces CEO Transition As Part Of Succession Planning

  3/6/2017

• Berkeley Lights And Mount Sinai School of Medicine Expand Relationship

  2/2/2017